Yale Podnos

Yale Podnos is a declared insider of Starling Oncology, Inc., with filings sourced from SEC (Form 4). The record holds 24 filings, for trades running from 12 November 2021 to 14 July 2026.

On the open market, the record shows 1 purchase worth €8,745 and 3 sales worth €132k. Taken together, the sales exceed the purchases by €124k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 9 share grants and 2 option exercises. So far in 2026, the count stands at no purchases and 2 sales.

The latest filing, published on 16 July 2026, reports an option exercise of €30k in Starling Oncology, Inc. The clock since the last published purchase (28 March 2025) now reads 569 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.